BRAF and melanoma: Treatment of malignant melanoma was a thorny problem decades ago, and now, due to the development of immunotherapy and the emergence of BRAF suppression methods, these treatments have been greatly improved; however, some malignant melanomas are still prone to recurrence or even metastasis.174